| Dokumenttyp | Erscheinungsjahr | Titel | Autoren | Herausgeber |
|---|
| article | 2024 | Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study) | Rosar, Florian; Schuler, Joelle; Burgard, Caroline; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Khreish, Fadi; Schaefer, Andrea; Ezziddin, Samer | |
| article | 2024 | Efficacy and safety of rechallenge [177Lu]Lu-PSMA-617 RLT after initial partial remission in patients with mCRPC: evaluation of a prospective registry (REALITY study) | Rosar, Florian; Schuler, Joelle; Burgard, Caroline; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Khreish, Fadi; Schaefer, Andrea; Ezziddin, Samer | |
| article | 2024 | Change of glucometabolic activity per PSMA expression predicts survival in mCRPC patients non-responding to PSMA radioligand therapy: introducing a novel dual imaging biomarker | Burgard, Caroline; Engler, Jakob; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Schaefer-Schuler, Andrea; Khreish, Fadi; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform | Martin, Sebastian; Schreck, Moritz-Valentin; Stemler, Tobias; Maus, Stephan; Rosar, Florian; Burgard, Caroline; Schaefer-Schuler, Andrea; Ezziddin, Samer; Bartholomä, Mark D. | |
| article | 2024 | [89Zr]Zr-PSMA-617 PET/CT characterization of indeterminate [68Ga]Ga-PSMA-11 PET/CT findings in patients with biochemical recurrence of prostate cancer: lesion-based analysis | Rosar, Florian; Burgard, Caroline; Larsen, Elena; Khreish, Fadi; Marlowe, Robert J.; Schaefer-Schuler, Andrea; Maus, Stephan; Petto, Sven; Bartholomä, Mark; Ezziddin, Samer | |
| article | 2024 | [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617 | Schaefer-Schuler, Andrea; Burgard, Caroline; Blickle, Arne; Maus, Stephan; Petrescu, Christine; Petto, Sven; Bartholomä, Mark; Stemler, Tobias; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Concomitant lithium increases radioiodine uptake and absorbed doses per administered activity in graves' disease: comparison of conventional versus lithium-augmented radioiodine therapy | Khreish, Fadi; Schaefer-Schuler, Andrea; Roth, Leonie; Burgard, Caroline; Rosar, Florian; Ezziddin, Samer | |
| article | 2024 | Outcome and Renal Safety of PSMA-Targeted Radioligand Therapy in mCRPC Patients With Preexisting Impaired Renal Function | Bastian, Moritz B.; Sieben, Maike; Burgard, Caroline; Blickle, Arne; Speicher, Tilman; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Schaefer-Schuler, Andrea; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT | Rosar, Florian; Burgard, Caroline; David, Scott; Marlowe, Robert J.; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Khreish, Fadi; Schaefer-Schuler, Andrea; Ezziddin, Samer | |
| article | 2024 | Analysis of Molecular Imaging and Laboratory Baseline Biomarkers in PSMA-RLT: Whole-Body Total Lesion PSMA (TLP) Predicts Overall Survival | Hein, Connor; Burgard, Caroline; Blickle, Arne; Bastian, Moritz B.; Maus, Stephan; Schaefer-Schuler, Andrea; Hoffmann, Manuela A.; Schreckenberger, Mathias; Ezziddin, Samer; Rosar, Florian | |
| article | 2024 | Analysis of Molecular Imaging Biomarkers Derived from [18F]FDG PET/CT in mCRPC: Whole-Body Total Lesion Glycolysis (TLG) Predicts Overall Survival in Patients Undergoing [225Ac]Ac-PSMA-617-Augmented [177Lu]Lu-PSMA-617 Radioligand Therapy | Burgard, Caroline; Khreish, Fadi; Dahlmanns, Lukas; Blickle, Arne; Bastian, Moritz B.; Speicher, Tilman; Maus, Stephan; Schaefer-Schuler, Andrea; Bartholomä, Mark; Petto, Sven; Ezziddin, Samer; Rosar | |
| article | 2024 | Outstanding increase in tumor-to-background ratio over time allows tumor localization by [89Zr]Zr-PSMA-617 PET/CT in early biochemical recurrence of prostate cancer | Burgard, Caroline; Rosar, Florian; Larsen, Elena; Khreish, Fadi; Linxweiler, Johannes; Marlowe, Robert J.; Schaefer-Schuler, Andrea; Maus, Stephan; Petto, Sven; Bartholomä, Mark; Ezziddin, Samer | |
| article | 2023 | Tumor Sink Effect with Prostate-Specific Membrane Antigen-Targeted Theranostics in Patients with Metastatic Castration-Resistant Prostate Cancer: Intra-Individual Evaluations | Burgard, Caroline; Rosar, Florian; Marlowe, Robert J.; Bartholomä, Mark; Dewes, Sebastian; Schaefer-Schuler, Andrea; Linxweiler, Johannes; Khreish, Fadi; Ezziddin, Samer | |
| article | 2023 | Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer | Rosar, Florian; Khreish, Fadi; Marlowe, Robert J.; Schaefer-Schuler, Andrea; Burgard, Caroline; Maus, Stephan; Petto, Sven; Bartholomä, Mark; Ezziddin, Samer | |
| article | 2023 | Change in total lesion PSMA (TLP) during [177Lu]Lu-PSMA-617 radioligand therapy predicts overall survival in patients with mCRPC: monocentric evaluation of a prospective registry | Burgard, Caroline; Hein, Connor; Blickle, Arne; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Schaefer-Schuler, Andrea; Ezziddin, Samer; Rosar, Florian | |
| article | 2022 | [89Zr]Zr-PSMA-617 PET/CT in biochemical recurrence of prostate cancer : first clinical experience from a pilot study including biodistribution and dose estimates | Rosar, Florian; Schaefer-Schuler, Andrea; Bartholomä, Mark; Maus, Stephan; Petto, Sven; Burgard, Caroline; Privé, Bastiaan M.; Franssen, Gerben M.; Derks, Yvonne H. W.; Nagarajah, James; Khreish, Fadi; Ezziddin, Samer | |
| article | 2021 | Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy | Rosar, Florian; Schön, Niklas; Bohnenberger, Hendrik; Bartholomä, Mark; Stemler, Tobias; Maus, Stephan; Khreish, Fadi; Ezziddin, Samer; Schaefer-Schuler, Andrea | |
| article | 2020 | New insights in the paradigm of upregulation of tumoral PSMA expression by androgen receptor blockade : Enzalutamide induces PSMA upregulation in castration-resistant prostate cancer even in patients having previously progressed on enzalutamide | Rosar, Florian; Dewes, Sebastian; Ries, Martin; Schaefer, Andrea; Khreish, Fadi; Maus, Stephan; Bohnenberger, Hendrik; Linxweiler, Johannes; Bartholomä, Mark; Ohlmann, Carsten; Ezziddin, Samer | |
